Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Research
Federal mRNA vax grant cuts includes unrelated project
Tiba Biotech's siRNA flu therapeutic was included in the BARDA mRNA vaccine cuts for unclear reasons.
Darren Incorvaia
Aug 7, 2025 2:20pm
Lilly's oral GLP-1 tied to 12% weight loss in phase 3 trial
Aug 7, 2025 6:30am
Fierce Biotech Layoff Tracker 2025: Iovance, Precision & more
Aug 7, 2025 2:39pm
Denali Alzheimer's antibody clears plaques without ARIA in mice
Aug 7, 2025 2:00pm
Investor syndicate takes majority stake in HistoSonics
Aug 7, 2025 1:16pm
FTC aims to stop Edwards’ acquisition of JenaValve
Aug 7, 2025 11:33am
More News
Big Pharmas back Strand's $153M series B to advance mRNA drugs
Aug 7, 2025 9:20am
Fierce Biotech Fundraising Tracker: Chai, Artbio & more
Aug 7, 2025 9:00am
Lilly shakes up pain pipeline as part of quarterly R&D clearout
Aug 7, 2025 8:28am
Minghui raises $131M to fund JAK inhibitor launch, ADC trials
Aug 7, 2025 8:15am